Retatrutide
$160.00
Retratrutide is a cutting-edge triple agonist (GLP-1, GIP, and glucagon) delivering powerful weight loss, appetite suppression, and metabolic regulation.
- Usage: Start at 2mg EW for 2 weeks, then titrate upward.
- Cycle Duration: Long-term use, minimum 1 month.
- Safety: May cause nausea, mild GI discomfort, or fatigue.
- Effects: Enhances fat loss, suppresses appetite, supports insulin sensitivity.
- Stack With: Tirzepatide, Clenbuterol, or Yohimbine.
Related products
What is Retratrutide by SYN Pharma?
Retratrutide (12mg / vial) by SYN Pharma is a next-generation research peptide designed as a triple agonist targeting GLP-1, GIP, and glucagon receptors. This unique mechanism makes it one of the most promising compounds for comprehensive metabolic regulation, supporting blood sugar balance, appetite suppression, fat loss, and potential lean muscle preservation.
Originally investigated for type 2 diabetes and obesity, Retratrutide has shown powerful effects on weight reduction and metabolic health, often surpassing traditional GLP-1 agonists. By activating multiple metabolic pathways, it enhances energy expenditure, improves insulin sensitivity, and supports long-term body composition improvements.
SYN Pharma’s Retratrutide comes as a lyophilized powder and is intended to be reconstituted with bacteriostatic water prior to subcutaneous administration.
Benefits of Retratrutide
- Triple receptor activation for enhanced fat loss and metabolism
- Potent appetite suppression and reduced food intake
- May support lean muscle retention during weight loss
- Improves insulin response and blood sugar control
- Potential cardiovascular and anti-inflammatory benefits
Product Details
- Compound: Retratrutide (GLP-1/GIP/Glucagon Receptor Agonist)
- Form: Lyophilized peptide powder
- Reconstitution: Mix with bacteriostatic water before use
- Administration: Subcutaneous injection, 1x per week
- Storage: Refrigerate after mixing
Recommended Usage Guidelines
- Starting Dose: 2 mg once weekly
- Increase: Gradually increase to 4–6 mg weekly as tolerated
- Maximum: Up to 8–12 mg weekly for advanced protocols
- Cycle Duration: 8–16+ weeks (long-term use possible)
- Injection Site: Subcutaneous (abdomen or thigh)
12-Week Retratrutide Weight Loss Protocol
| Week | Retratrutide Dose (mg) | Injection Frequency | Notes |
| 1–2 | 2 mg | Once weekly | Introductory phase to assess tolerance |
| 3–4 | 4 mg | Once weekly | Appetite control and steady fat loss |
| 5–8 | 6 mg | Once weekly | Accelerated fat loss phase |
| 9–12 | 8–10 mg | Once weekly | Advanced phase; adjust or taper based on results |
Common Questions About Retratrutide
Do I need to mix Retratrutide before use?
Yes. SYN Pharma’s Retratrutide is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water. After mixing, it should be stored in the refrigerator and used within its shelf life.
How soon will I see results?
Appetite suppression and metabolic effects may appear within the first 1–2 weeks. Noticeable fat loss and body composition improvements typically begin around weeks 3–5, especially when combined with a calorie-controlled diet.
Can Retratrutide be used by non-diabetics?
Yes. While developed for type 2 diabetes, Retratrutide is widely studied off-label in non-diabetic individuals for research into obesity and metabolic health.
Are there any side effects?
Common side effects may include nausea, gastrointestinal discomfort, or mild fatigue. These typically resolve as the body adjusts. Starting at a low dose helps minimize them.
Be the first to review “Retatrutide”
You must be logged in to post a review.
EXTREMELY LIMITED AVAILABILITY — UPDATED AUGUST 16TH, 2025
CURRENTLY OUT OF STOCK – no confirmed ETA:
Reviews
There are no reviews yet.